ArticleNature genetics2019
Priority index for human genetics and drug discovery.
Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects.Nature genetics · 2022Pooled it
- Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes.eLife · 2020Pooled it
- Preparing for Polygenic Risk Scores in the Clinic: An Accessible Guide to Reading and Interpreting Genome-Wide Association Studies.Dermatology (Basel, Switzerland) · 2025Article
- Priority index for critical Covid-19 identifies clinically actionable targets and drugs.Communications biology · 2024Article
- Genetic and Gene Expression Resources for Osteoporosis and Bone Biology Research.Current osteoporosis reports · 2023Review
- Pharmacogenomics: Driving Personalized Medicine.Pharmacological reviews · 2023Review
- The impact of rare protein coding genetic variation on adult cognitive function.Nature genetics · 2023Article
- Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.Nutrition, metabolism, and cardiovascular diseases : NMCD · 2022Article
- Priority index: database of genetic targets in immune-mediated disease.Nucleic acids research · 2022Article
- Recent advances in understanding the genetic basis of systemic lupus erythematosus.Seminars in immunopathology · 2022Review
- Target Discovery for Drug Development Using Mendelian Randomization.Methods in molecular biology (Clifton, N.J.) · 2022Review
- Integrative Network-Based Analysis Reveals Gene Networks and Novel Drug Repositioning Candidates for Alzheimer Disease.Neurology. Genetics · 2021Article
- Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021Review
- Identifying therapeutic drug targets using bidirectional effect genes.Nature communications · 2021Article
- RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice.Nature metabolism · 2020Article
- Tissue-specific genetic features inform prediction of drug side effects in clinical trials.Science advances · 2020Article
- Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond.Cells · 2019Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
31253975What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.